These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 31835505)

  • 1. Weight Gain and
    Lattanzi B; D'Ambrosio D; Tavano D; Pitoni D; Mennini G; Ginanni Corradini S; Rossi M; Merli M
    Nutrients; 2019 Dec; 11(12):. PubMed ID: 31835505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of de novo post-transplant type 2 diabetes in patients undergoing liver transplant for non-alcoholic steatohepatitis.
    Stepanova M; Henry L; Garg R; Kalwaney S; Saab S; Younossi Z
    BMC Gastroenterol; 2015 Dec; 15():175. PubMed ID: 26666336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of De Novo Nonalcoholic Fatty Liver Disease After Liver Transplantation and Associated Fibrosis.
    Galvin Z; Rajakumar R; Chen E; Adeyi O; Selzner M; Grant D; Sapisochin G; Greig P; Cattral M; McGilvray I; Ghanekar A; Selzner N; Lilly L; Patel K; Bhat M
    Liver Transpl; 2019 Jan; 25(1):56-67. PubMed ID: 30609189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and Risks for Nonalcoholic Fatty Liver Disease and Steatohepatitis Post-liver Transplant: Systematic Review and Meta-analysis.
    Saeed N; Glass L; Sharma P; Shannon C; Sonnenday CJ; Tincopa MA
    Transplantation; 2019 Nov; 103(11):e345-e354. PubMed ID: 31415032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High incidence of hepatocellular carcinoma and postoperative complications in patients with nonalcoholic steatohepatitis as a primary indication for deceased liver transplantation.
    Kern B; Feurstein B; Fritz J; Fabritius C; Sucher R; Graziadei I; Bale R; Tilg H; Zoller H; Newsome P; Eschertzhuber S; Margreiter R; Öfner D; Schneeberger S
    Eur J Gastroenterol Hepatol; 2019 Feb; 31(2):205-210. PubMed ID: 30320609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histologically proven non-alcoholic fatty liver disease and clinically related factors in recipients after liver transplantation.
    Kim H; Lee K; Lee KW; Yi NJ; Lee HW; Hong G; Choi Y; You T; Suh SW; Jang JJ; Suh KS
    Clin Transplant; 2014 May; 28(5):521-9. PubMed ID: 24579874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonalcoholic steatohepatitis in posttransplantation liver: Review article.
    Andrade ARCF; Cotrim HP; Bittencourt PL; Almeida CG; Sorte NCAB
    Rev Assoc Med Bras (1992); 2018 Feb; 64(2):187-194. PubMed ID: 29641680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver transplantation for NASH cirrhosis is not performed at the expense of major post-operative morbidity.
    van den Berg EH; Douwes RM; de Meijer VE; Schreuder TCMA; Blokzijl H
    Dig Liver Dis; 2018 Jan; 50(1):68-75. PubMed ID: 28935188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New Onset Diabetes and Non-Alcoholic Fatty Liver Disease after Liver Transplantation.
    Andrade AR; Bittencourt PL; Codes L; Evangelista MA; Castro AO; Sorte NB; Almeida CG; Bastos JA; Cotrim HP
    Ann Hepatol; 2017 November-December,; 16(6):932-940. PubMed ID: 29055928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics and risk factors for recurrence of nonalcoholic steatohepatitis following liver transplantation.
    Tokodai K; Karadagi A; Kjaernet F; Romano A; Ericzon BG; Nowak G
    Scand J Gastroenterol; 2019 Feb; 54(2):233-239. PubMed ID: 30999770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of liver transplantation in patients with prior bariatric surgery.
    Safwan M; Collins KM; Abouljoud MS; Salgia R
    Liver Transpl; 2017 Nov; 23(11):1415-1421. PubMed ID: 28752920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent or De Novo Allograft Steatosis and Long-term Outcomes After Liver Transplantation.
    Narayanan P; Mara K; Izzy M; Dierkhising R; Heimbach J; Allen AM; Watt KD
    Transplantation; 2019 Jan; 103(1):e14-e21. PubMed ID: 29994981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent or de novo nonalcoholic fatty liver disease after liver transplantation: natural history based on liver biopsy analysis.
    Vallin M; Guillaud O; Boillot O; Hervieu V; Scoazec JY; Dumortier J
    Liver Transpl; 2014 Sep; 20(9):1064-71. PubMed ID: 24961607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De Novo and Recurrence of Nonalcoholic Steatohepatitis After Liver Transplantation.
    Kappus M; Abdelmalek M
    Clin Liver Dis; 2017 May; 21(2):321-335. PubMed ID: 28364816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver Transplantation for Nonalcoholic Steatohepatitis in the US: Temporal Trends and Outcomes.
    Cholankeril G; Wong RJ; Hu M; Perumpail RB; Yoo ER; Puri P; Younossi ZM; Harrison SA; Ahmed A
    Dig Dis Sci; 2017 Oct; 62(10):2915-2922. PubMed ID: 28744836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Weight gain after orthotopic liver transplantation: is nonalcoholic fatty liver disease cirrhosis a risk factor for greater weight gain?
    Kouz J; Vincent C; Leong A; Dorais M; Räkel A
    Liver Transpl; 2014 Oct; 20(10):1266-74. PubMed ID: 25044355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of Recurrent NASH-Related Allograft Cirrhosis.
    Kakar S; Dugum M; Cabello R; Humar A; Ahmad J; Malik SM
    Dig Dis Sci; 2019 May; 64(5):1356-1363. PubMed ID: 30560336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Equivalent survival following liver transplantation in patients with non-alcoholic steatohepatitis compared with patients with other liver diseases.
    Kennedy C; Redden D; Gray S; Eckhoff D; Massoud O; McGuire B; Alkurdi B; Bloomer J; DuBay DA
    HPB (Oxford); 2012 Sep; 14(9):625-34. PubMed ID: 22882200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonalcoholic Steatohepatitis is the Most Rapidly Increasing Indication for Liver Transplantation in Young Adults in the United States.
    Doycheva I; Issa D; Watt KD; Lopez R; Rifai G; Alkhouri N
    J Clin Gastroenterol; 2018 Apr; 52(4):339-346. PubMed ID: 28961576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lower rates of receiving model for end-stage liver disease exception and longer time to transplant among nonalcoholic steatohepatitis hepatocellular carcinoma.
    Young K; Aguilar M; Gish R; Younossi Z; Saab S; Bhuket T; Liu B; Ahmed A; Wong RJ
    Liver Transpl; 2016 Oct; 22(10):1356-66. PubMed ID: 27348270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.